YOLFTbeta
Prescient Therapeutics Ltd

Prescient Therapeutics Ltd

PTX · AU · Healthcare / Biotechnology

0.058AUD-0.00 (-7.94%)

Price History

Full chart

Market Stats

Previous Close0.063
Open0.063
Day Range0.058 – 0.063
52-Week Range0.041 – 0.125
Volume112.89K
Market Cap75.49M
P/E (TTM)0.00
Forward P/E5.48
EPS-0.01
Dividend Yield0.00%
Beta0.75
50-Day Avg0.074
200-Day Avg0.069

About

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first-in-class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. The company is also developing cell therapy platforms, including CellPryme, a high-performance cell therapy enhancement platform; and OmniCAR, is a platform seeks to overcome the challenges of conventional CAR-T therapy including manufacturing, safety and reliability. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. James McDonnell
  • Employees0
  • HeadquartersSuite 2, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://ptxtherapeutics.com

Leadership

  • Mr. James McDonnellChief Executive Officer
  • Ms. Melanie Jaye Leydin B.Bus, C.A.CFO & Company Secretary · b. 1973
  • Dr. Rebecca TunstallChief Operating Officer
  • Dr. Rosalind Wilson M.B.A., MBBSChief Medical Officer

Financials

Income Statement

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-----------272.00K712.00K435.00K154.05K175.00K1.42M209.00K1.54M521.00K-----8.14K39.97K10.70K166.22K939.77K72.11K1.03M1.19M1.89M2.43M3.71M4.36M-
Growth (%)------------+161.76%-38.90%-64.59%+13.60%+711.43%-85.28%+638.28%-66.23%------+390.91%-73.22%+1452.88%+465.38%-92.33%+1326.99%+15.16%+59.41%+28.53%+52.88%+17.36%-
Cost of Revenue--------------3.30M----------001716051.47K1.34K9044741.40K2.09K717-110.34K
Gross Profit-------------435.00K-3.15M-1.42M209.00K3.53M521.00K-----8.14K251.09K10.70K1.22M938.30K1.65M1.03M1.19M1.89M2.43M3.71M4.36M-110.34K
Gross Margin-------------100.00%-2042.19%-100.00%100.00%228.90%100.00%-----100.00%628.19%100.00%736.52%99.84%2285.06%99.90%100.00%99.95%99.92%100.00%100.00%-
Operating Expense-------------3.62M218.09K-5.69M4.99M8.30M2.87M-----933.00K2.64M2.75M4.99M4.54M5.44M5.52M6.61M8.99M12.31M10.90M11.89M10.48M
Operating Income-178.00K710.00K202.00K92.00K-94.00K-1.21M17.00K98.08K-1.31M-1.03M-2.85M-2.42M-3.01M-3.19M-3.36M-4.14M-4.27M-4.79M-4.77M-2.35M-1.71M-2.10M-2.07M-2.10M-455.00K-924.86K-2.38M-2.74M-3.76M-3.61M-3.79M-4.49M-5.43M-7.10M-9.89M-7.19M-7.54M-10.59M
Operating Margin------------888.24%-422.19%-732.41%-2183.76%-2365.14%-300.70%-2289.47%-309.27%-450.29%------11359.08%-5965.63%-25587.59%-2263.84%-383.71%-5261.30%-436.73%-457.98%-375.81%-407.17%-193.59%-172.98%-
EBITDA-178.00K710.00K202.00K92.00K-94.00K-1.21M17.00K98.08K-1.31M-1.03M-2.85M-2.42M-3.00M-3.17M-3.35M-4.08M-5.25M-4.78M-4.76M-1.66M-1.07M-1.67M-1.29M-1.96M-453.00K-462.05K-53.20K-1.75M-2.54M-2.67M-5.54M-3.46M-5.32M-6.86M-7.46M-7.19M-7.54M-10.48M
EBITDA Margin------------888.24%-421.07%-729.66%-2172.73%-2328.57%-369.44%-2287.56%-308.49%-318.43%------5674.93%-133.09%-16320.34%-1526.40%-283.58%-7687.89%-336.64%-449.22%-363.17%-307.08%-193.59%-172.96%-
Net Income-92.00K200.00K-220.00K-21.00K-23.00K-20.00K-8.00K--1.31M-1.03M-1.43M-2.42M-2.29M-2.65M-3.13M-3.96M-4.00M-4.63M-2.67M-1.77M-1.35M-1.86M-1.36M-1.89M1.79M-1.30M-2.13M-1.75M-2.57M-2.57M-3.80M-3.32M-4.15M-5.12M-7.00M-8.24M-7.32M-7.00M
Net Income Margin------------889.34%-322.05%-608.51%-2035.11%-2264.57%-281.62%-2212.92%-172.85%-340.31%------15928.47%-5337.44%-16387.72%-1544.72%-273.90%-5265.88%-322.74%-350.13%-270.88%-288.51%-221.93%-168.09%-
R&D-----------1.85M1.87M1.28M1.39M2.01M2.37M1.99M2.46M997.00K580.00K389.00K593.00K584.27K2.10K986.34K986.34K797.89K2.43M2.06M3.68M2.76M2.50M3.40M6.22M6.97M6.72M5.28M
R&D as % of Total Revenue-----------681.62%262.92%294.02%901.03%1148.57%167.18%951.20%159.43%191.36%-----12114.27%2467.71%7454.12%1463.22%218.88%5106.54%268.22%210.55%179.99%256.26%187.85%154.18%-
Interest Expense282.00K299.00K200.00K295.00K208.00K200.00K233.00K00003.00K0000000104.26K275.85K193.00K139.00K69.27K000002.20K3.30K4.19K10.62K6.53K---10.70K
Interest Expense % of Total Revenue-----------1.10%0.00%0.00%0.00%0.00%0.00%0.00%0.00%20.01%-----0.00%0.00%0.00%0.00%0.23%4.58%0.41%0.90%0.35%----

Balance Sheet

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets6.56M7.18M7.08M6.85M5.55M5.90M2.25M24.16K161.76K1.24M2.80M1.38M4.28M1.90M1.63M4.15M4.18M3.71M3.24M1.75M1.18M1.57M701.86K61.82K-5.28M4.89M13.84M12.23M9.99M15.01M12.07M20.97M17.62M28.11M20.39M14.56M16.28M
Total Liabilities5.49M5.39M5.42M5.67M5.00M5.57M2.38M65.70K137.43K61.98K119.70K107.61K667.73K448.42K680.00K510.81K1.35M1.68M1.48M1.68M1.79M1.29M1.53M1.85M-252.89K441.13K822.55K444.89K551.56K685.79K883.95K539.68K856.01K2.03M2.33M3.17M2.08M
Total Equity1.04M1.54M1.42M1.17M546.00K336.00K-134.00K-41.55K24.34K1.17M2.68M1.28M3.61M1.46M953.60K3.64M2.83M2.03M1.77M73.05K-604.48K278.83K-832.03K-1.79M-5.03M4.45M13.01M11.78M9.44M14.32M11.19M20.43M16.76M26.08M18.07M11.39M14.20M
Cash75.00K1.36M285.00K223.00K11.00K20.00K663.00K24.16K150.00K1.02M2.72M1.35M-125.00K260.00K436.00K162.00K1.56M3.55M1.57M1.63M1.07M1.38M585.00K29.18K-3.81M1.04M9.75M7.65M5.49M9.64M7.36M16.10M12.26M5.90M10.49M6.91M9.03M
Total Debt2.60M2.43M2.25M2.98M1.84M2.06M1.01M------------1.30M1.51M897.00K1.03M1.10M-----56.05K156.88K156.88K165.83K--330.49K-222.97K
Net Debt2.52M1.07M1.97M2.76M1.83M2.04M347.00K-24.16K-150.00K-1.02M-2.72M-1.35M125.00K-260.00K-436.00K-162.00K-1.56M-3.55M-1.57M-326.00K437.00K-487.00K450.00K1.07M--3.81M-1.04M-9.75M-7.65M-5.43M-9.64M-7.20M-15.93M-12.26M-5.90M-10.16M-6.91M-8.81M

Cash Flow

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--730.00K-1.74M-662.00K-1.88M-720.86K-893.39K-1.30M-1.23M-2.23M-2.23M-2.39M-3.21M-3.78M-2.81M-4.25M-4.28M-1.22M-1.18M-948.56K-798.32K-1.06M-29.18K-1.13M-2.24M-1.56M-3.28M-2.15M-4.20M-2.32M-3.97M-4.31M-6.19M-7.40M-7.24M-7.22M
Investing Cash Flow---635.00K-689.00K-390.00K-373.00K4.56M226.79K-303.65K-10.12K-399-6.61K-20.78K-14.40K-29.23K-300.03K-83.70K-25.72K-5.79K-1.45K27.27K-4.32K-889---144.38K-525.01K2.46K-21.69K-1.52K-2.31K-2.31K-2.31K-4.43K-16.00M12.00M4.00M-
Financing Cash Flow---945.00K274.00K-1.54M878.00K-1.79M-122.85K1.32M2.18M2.93M880.83K4.63M489.06K2.96M6.35M3.19M3.72M2.31M1.28M595.97K1.27M-503.74K-5.08M10.28M10.28M1.22M-6358.37M12.75M12.75M428.29K15.83M18.15K-330.49K9.34M
Capital Expenditure00269.00K181.00K562.00K498.00K0011.50K10.12K3996.61K20.78K14.40K29.23K300.03K83.70K25.72K5.79K1.45K04.32K88900144.38K525.01K1.32K1.69K1.52K2.31K2.31K2.31K4.43K0300
Free Cash Flow--461.00K-181.00K1.18M-1.16M-1.88M-720.86K-904.89K-1.31M-1.23M-2.24M-2.25M-2.40M-3.24M-4.08M-2.89M-4.28M-4.29M-1.22M-1.18M-952.87K-799.21K-1.06M-29.18K-1.27M-2.77M-1.56M-3.28M-2.15M-4.20M-2.32M-3.97M-4.32M-6.19M-7.40M-7.24M-7.22M
Dividends Paid--261.00K11.00K34.00K322.00K17.00K----------------------2.47K7.67M-12.75M-----
FCF to OCF--63.15%-67.68%175.23%100.00%100.00%101.29%100.78%100.03%100.30%100.93%100.60%100.91%107.94%102.98%100.60%100.14%100.12%100.00%100.46%100.11%100.00%100.00%112.81%123.43%100.08%100.05%100.07%100.00%100.00%100.06%100.10%100.00%100.00%100.00%100.00%
Dividend Paid to FCF--56.62%-6.08%2.89%-27.76%-0.91%-----------------------0.11%-182.75%--320.96%-----

Earnings

Report DateFeb 17, 2016Aug 31, 2016Feb 23, 2017Aug 29, 2017Feb 27, 2018Aug 31, 2018Feb 21, 2019Aug 25, 2019Feb 27, 2020Aug 25, 2020Feb 24, 2021Aug 30, 2021Feb 24, 2022Aug 22, 2022Feb 24, 2023Feb 20, 2025Aug 20, 2025
EPS Estimate0.000.000.000.000.000.000.00-0.010.00-0.000.00-0.01-0.010.000.000.000.00
EPS Actual-0.01-0.010.00-0.01-0.01-0.01-0.01-0.010.000.000.000.000.000.000.000.00-0.01
Surprise--------2.04%-100.00%-100.00%100.00%----
Timing-------------After-hoursAfter-hours--

Key Statistics & Ratios

Market Cap75.49M
Enterprise Value61.63M
Trailing P/E0.00
Forward P/E5.48
Price / Sales21.88
Price / Book4.96
EPS-0.01
Book Value0.014
Revenue (TTM)3.45M
Gross Profit (TTM)3.45M
EBITDA-7.03M
Profit Margin-202.91%
Operating Margin-137.67%
Return on Equity-54.73%
Return on Assets-28.94%
Shares Outstanding1.14B
Shares Float894.03M
Beta0.75
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19931×
16.93Oct 21, 1993

Stock Splits

  • Mar 28, 201956:55
  • May 25, 201640:39
  • Dec 2, 20141:20
  • Sep 4, 20131:10
  • May 27, 201136:35
  • Nov 29, 2005176:173
  • Sep 18, 2002115:112
  • Jul 17, 199720:19
  • Sep 27, 19961:2